Medical Doctor Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Anchit Mehrotra

Surgery Sun City West, AZ Medical Doctor

NPI 1922494525 CMS profile 11307025

14414 W. Meeker Blvd, Building C, Suite 100, Sun City West, AZ 85375

Open in the dashboard

General payments

$39,685

140 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Anchit Mehrotra of Sun City West, AZ is reported in the CMS Open Payments database as having received $39,685 across 140 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 95th percentile of Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,944 36
2024 General $7,848 25
2023 General $24,591 47
2022 General $5,212 28
2021 General $91 4

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Anchit Mehrotra
  • Surgery median
  • Middle half of Surgery
  • National median

In program year 2025, general payments to Anchit Mehrotra were reported at $1,944. Among 17,702 Surgery profiles paid that year, the median was $280 and the middle half received between $91 and $1,259.

Show as a table
Year Anchit Mehrotra Surgery median Middle half National median
2019 $0 $253 $82–$1,521 $163
2020 $0 $131 $40–$706 $114
2021 $91 $168 $50–$904 $132
2022 $5,212 $224 $76–$1,218 $149
2023 $24,591 $253 $82–$1,255 $160
2024 $7,848 $279 $90–$1,381 $164
2025 $1,944 $280 $91–$1,259 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Intuitive Surgical, Inc. $35,195 75 payments
  2. Medtronic, Inc. $1,749 29 payments
  3. NuVasive, Inc. $1,259 10 payments
  4. Davol Inc. $918 10 payments
  5. Smith+Nephew, Inc. $139 4 payments
  6. Solventum Corporation $127 5 payments
  7. Medical Device Business Services, Inc. $125 1 payment
  8. Ethicon US, LLC $73 2 payments
  9. Biom'Up France SAS $53 2 payments
  10. Boston Scientific Corporation $31 1 payment
  11. Other $17 1 payment

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Education $25,060 12 payments
  2. Travel and Lodging $8,979 47 payments
  3. Food and Beverage $5,108 77 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $500 1 payment
  5. Gift $39 3 payments
Products named General payments · program years 2021–2025
  1. Da Vinci Surgical System $20,902 62 payments
  2. DAVINCI XI $13,000 7 payments
  3. DA VINCI SP $1,293 6 payments
  4. ALIF $1,259 10 payments
  5. CD HORIZON SPINAL SYSTEM $982 19 payments
  6. Signia $736 9 payments
  7. Phasix Mesh BD Interventional Surgery $522 5 payments
  8. Phasix Mesh Surgery $363 4 payments
  9. VISTASEAL $125 1 payment
  10. ACTIV.A.C. $79 3 payments
  11. Other $490 17 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

207

Median for General Surgery: 59

Drug cost

$1,845

Median for General Surgery: $393

Branded share of claims

50.2%

Median for General Surgery: 28.9%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Ondansetron Odt Ondansetron Brand 104 $845
Naloxone Hcl Generic 13 $777
Oxycodone Hcl Generic 90 $222

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 15,891 Part D prescribers listed as General Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 55 billing codes

Paid by Medicare

$70,572

Medicare's payments for the services billed

Medicare patients

209

Average age 76

Services billed

451

107 women, 102 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 59%
Chronic kidney disease 48%
Ischemic heart disease 39%
Diabetes 38%
Atrial fibrillation 34%
Depression 33%
Heart failure 28%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

140 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery in Arizona

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record